Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Can NSAIDs and prostaglandin analogues be combined?

× No keyword cloud information.

14 in total

Review 1. From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.

Authors: J W Stjernschantz
Journal: Invest Ophthalmol Vis Sci Date: 2001-05 Impact factor: 4.799

2. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells.

Authors: J D Lindsey; K Kashiwagi; D Boyle; F Kashiwagi; G S Firestein; R N Weinreb
Journal: Curr Eye Res Date: 1996-08 Impact factor: 2.424

3. Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes.

Authors: J Villumsen; A Alm
Journal: Br J Ophthalmol Date: 1989-06 Impact factor: 4.638

4. Acetylsalicylic acid does not reduce the intraocular pressure variation in ocular hypertension or glaucoma.

Authors: C Lindén; A Alm
Journal: Exp Eye Res Date: 2000-03 Impact factor: 3.467

5. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.

Authors: Ciro Costagliola; Francesco Parmeggiani; Paolo Pio Antinozzi; Antonio Caccavale; Luigi Cotticelli; Adolfo Sebastiani
Journal: Exp Eye Res Date: 2005-06-08 Impact factor: 3.467

6. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.

Authors: K Kashiwagi; S Tsukahara
Journal: Br J Ophthalmol Date: 2003-03 Impact factor: 4.638

7. Inhibition of the epinephrine-induced reduction of intraocular pressure by systemic indomethacin in humans.

Authors: C B Camras; S G Feldman; S M Podos; R E Christensen; S K Gardner; D T Fazio
Journal: Am J Ophthalmol Date: 1985-07-15 Impact factor: 5.258

8. Prostaglandins F2alpha and E2 in aqueous humor of patients with cataract surgery.

Authors: Toshihiko Matsuo
Journal: J Ocul Pharmacol Ther Date: 2004-04 Impact factor: 2.671

9. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.

Authors: N Ziai; J W Dolan; R D Kacere; R F Brubaker
Journal: Arch Ophthalmol Date: 1993-10

10. PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers.

Authors: A Alm; J Villumsen
Journal: Arch Ophthalmol Date: 1991-11